BRVO- branch retinal vein occlusion ; CRVO- central retinal vein occlusion ; TIA- transient ischemic attack
1. OZURDEX is not recommended during pregnancy unless the potential benefit justifies the potential risk to the foetus. Ozurdex prescribing information. Nov2019
2. OZURDEX is not recommended during breast feeding unless clearly necessary. Ozurdex prescribing information. Nov2019
* Bevacizumab is not licensed for ophthalmic use. Allergan does not endorse unlicensed use of any product.
^For full information please refer to the ministry of health (MOH) circular for the national health basket expansion 2021.
Refrences:
- Ozurdex - Prescribing Information
- National health basket expansion 2021
- Zur D, et al. Ophthalmic Res. 2019;62:231–236
IL-OZU-230034